Fusao Komada, Yuko Nakayama, Kohji Takara. Analysis of time-to-onset and onset-pattern of interstitial lung disease after the administration of monoclonal antibody agents. Yakugaku Zasshi, 138(12):1587-1594(2018)
Fumiaki Kitazawa, Shin-ichi Fuchida, Yoko Kado, Kumi Ueda, Takatoshi Kokufu, Akira Okano, Mayumi Hatsuse, Satoshi Murakami, Yuko Nakayama, Kohji Takara, Chihiro Shimazaki. Pharmacokinetic interaction between tacrolimus and fentanyl in patients receiving allogeneic hematopoietic stem cell transplantation. Ann. Transplant., 22:575-580(2017)
Fumiaki Kitazawa, Shin-Ichi Fuchida, Fumitaka Ise, Yoko Kado, Kumi Ueda, Takatoshi Kokufu, Akira Okano, Mayumi Hatsuse, Satoshi Murakami, Yuko Nakayama, Kohji Takara, Chihiro Shimazaki. Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis. Oncol. Lett., 14(1):475-479(2017)
Fumiaki Kitazawa, Yoko Kado, Kumi Ueda, Takatoshi Kokufu, Shin-ichi Fuchida, Akira Okano, Mayumi Hatsuse, Satoshi Murakami, Yuko Nakayama, Kohji Takara, Chihiro Shimazaki. The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity. Mol. Clin. Oncol., 4(2):293-297(2016)
Atsushi Mizumoto, Kazuhiro Yamamoto, Yuko Nakayama, Kohji Takara, Tsutomu Nakagawa, Takeshi Hirano and Midori Hirai. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor constitutes to sunitinib resistance in human renal cell carcinoma cell lines. J. Pharmacol. Exp. Ther., 355(2):152-158(2015)
Yuko Nakayama, Kohji Takara, Tetsuya Minegaki, Kazuhiro Yamamoto, Ikuko Yano: Molecular characteristics of human leukemia cell line after the long-term exposure to the Bcl-2 inhibitor ABT-199. The 2nd International Cancer Research Symposium of Training Plan for Oncology Professionals, February, 2019, Osaka, Japan